Dr Shoban Arun Dave, MD | |
90 Health Park Dr, Suite 170, Louisville, CO 80027-9757 | |
(303) 862-3303 | |
(303) 862-3308 |
Full Name | Dr Shoban Arun Dave |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 23 Years |
Location | 90 Health Park Dr, Louisville, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558377317 | NPI | - | NPPES |
911932000 | Medicaid | MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 50487 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Centura Health-avista Adventist Hospital | Louisville, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Flatiron Allergy And Asthma Center | 8325262306 | 3 |
News Archive
The U.S. Food and Drug Administration (FDA) has awarded the Georgia Institute of Technology, Children's Healthcare of Atlanta, Emory University and Saint Joseph's Translational Research Institute (SJTRI) a two-year, $1.8 million grant to foster the development of medical devices focused on the special needs of children.
Despite bureaucratic hurdles, the vast majority of pediatricians want to keep participating in a national program that provides vaccinations at no cost to children who are on Medicaid, uninsured, or who are American Indian/Alaska Native, according to researchers at the University of Colorado Anschutz Medical Campus.
Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.
Results from a randomized study with Zyclara following cryotherapy in the treatment of actinic keratoses (AK) demonstrated Zyclara complemented the effectiveness of cryosurgery in reducing total AK count and achieving complete clearance of AK, according to data presented at the American Academy of Dermatology Summer Academy Meeting 2010 (Summer AAD), August 4 - 8.
A new research report published in the Journal of Leukocyte Biology shows how the bacteria known for causing gum disease-Porphyromonas gingivalis-manipulates the body's immune system to disable normal processes that would otherwise destroy it. Specifically, the report shows that this pathogen prompts the production of the anti-inflammatory molecule Interleukin-10 (IL-10).
› Verified 9 days ago
Entity Name | Flatiron Allergy & Asthma Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790107373 PECOS PAC ID: 8325262306 Enrollment ID: O20140612002191 |
News Archive
The U.S. Food and Drug Administration (FDA) has awarded the Georgia Institute of Technology, Children's Healthcare of Atlanta, Emory University and Saint Joseph's Translational Research Institute (SJTRI) a two-year, $1.8 million grant to foster the development of medical devices focused on the special needs of children.
Despite bureaucratic hurdles, the vast majority of pediatricians want to keep participating in a national program that provides vaccinations at no cost to children who are on Medicaid, uninsured, or who are American Indian/Alaska Native, according to researchers at the University of Colorado Anschutz Medical Campus.
Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.
Results from a randomized study with Zyclara following cryotherapy in the treatment of actinic keratoses (AK) demonstrated Zyclara complemented the effectiveness of cryosurgery in reducing total AK count and achieving complete clearance of AK, according to data presented at the American Academy of Dermatology Summer Academy Meeting 2010 (Summer AAD), August 4 - 8.
A new research report published in the Journal of Leukocyte Biology shows how the bacteria known for causing gum disease-Porphyromonas gingivalis-manipulates the body's immune system to disable normal processes that would otherwise destroy it. Specifically, the report shows that this pathogen prompts the production of the anti-inflammatory molecule Interleukin-10 (IL-10).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Shoban Arun Dave, MD 90 Health Park Dr, Suite 170, Louisville, CO 80027-9757 Ph: (303) 862-3303 | Dr Shoban Arun Dave, MD 90 Health Park Dr, Suite 170, Louisville, CO 80027-9757 Ph: (303) 862-3303 |
News Archive
The U.S. Food and Drug Administration (FDA) has awarded the Georgia Institute of Technology, Children's Healthcare of Atlanta, Emory University and Saint Joseph's Translational Research Institute (SJTRI) a two-year, $1.8 million grant to foster the development of medical devices focused on the special needs of children.
Despite bureaucratic hurdles, the vast majority of pediatricians want to keep participating in a national program that provides vaccinations at no cost to children who are on Medicaid, uninsured, or who are American Indian/Alaska Native, according to researchers at the University of Colorado Anschutz Medical Campus.
Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.
Results from a randomized study with Zyclara following cryotherapy in the treatment of actinic keratoses (AK) demonstrated Zyclara complemented the effectiveness of cryosurgery in reducing total AK count and achieving complete clearance of AK, according to data presented at the American Academy of Dermatology Summer Academy Meeting 2010 (Summer AAD), August 4 - 8.
A new research report published in the Journal of Leukocyte Biology shows how the bacteria known for causing gum disease-Porphyromonas gingivalis-manipulates the body's immune system to disable normal processes that would otherwise destroy it. Specifically, the report shows that this pathogen prompts the production of the anti-inflammatory molecule Interleukin-10 (IL-10).
› Verified 9 days ago